[ Price : $8.95]
The Better Business Bureaus National Advertising Division recommends that Alcon Laboratories stop making certain comparative super...[ Price : $8.95]
AcelRx Pharmaceuticals says it will resubmit early next year its NDA for pain drug Zalviso (sufentanil sublingual tablet system), ...[ Price : $8.95]
The Institute of Medicine posts a summary report of its public workshops held earlier this year on advancing the development of mo...[ Price : $8.95]
FDAs Office of Prescription Drug Promotion reopens for 30 days the comment period for two recent draft social media guidances.[ Price : $8.95]
FDA issues a drug safety alert on Genentechs Xolair (omalizumab) due to a slightly elevated risk of cardiovascular and cerebrovasc...[ Price : $8.95]
FDA says it has identified a potential safety signal with Novartis Zortress (everolimus) oral tablets, indicated for preventing ki...[ Price : $8.95]
Federal Register Notice: FDA reopens the comment period for a draft guidance on Informed Consent Information Sheet.[ Price : $8.95]
Federal Register Notice: FDA publishes list of approved PMAs and their safety and effectiveness summaries.